CooperVision brings a refreshing perspective on vision care across Asia
CooperVision is the third-largest soft contact lens supplier in the world and the second-largest in Asia-Pacific, with products sold in more than 100 countries
Asia’s shifting demographics, rapid urbanisation and changing environmental and lifestyle factors contribute to the region’s rising demand for vision care. It is estimated that around 80 to 90 per cent of the young adult population in Hong Kong, Taiwan, South Korea, Singapore and Japan are affected by myopia, or near sightedness.
Studies also predict that nearly half of the world’s population will be myopic by 2050, and high-income countries in Asia are particularly at risk.
CooperVision – a unit of United States-based global medical device firm The Cooper Companies – is bringing its refreshing perspective on vision care across Asia. CooperVision offers an extensive range of spherical, toric and multifocal contact lenses to correct vision problems such as myopia, astigmatism, presbyopia, ocular dryness and other basic eye care needs.
Founded in 1980, CooperVision is the third-largest soft contact lens supplier in the world and the second-largest in Asia-Pacific, with products sold in more than 100 countries. Its primary brands include MyDay, clariti, Biofinity, Avaira Vitality, Proclear and Biomedics.
In Asia-Pacific, the contact lens specialist has direct operations in eight countries. Its regional hub is in Singapore, where it nurtures a partnership with the state’s Economic Development Board. The company’s biggest regional market is Japan, followed by China, South Korea, Australia and New Zealand. CooperVision also operates in Taiwan, Hong Kong, Singapore and Malaysia and has long-standing relationships with various local distribution partners.
The company works with customers through a partnership-based, consultative approach. Its key partners in the region are eye care practitioners, specialised contact lens chains, retail and individual vision care product outlets.
